The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
MR angiography with blood pool contrast agents
Abstract
Contrast-enhanced magnetic resonance angiography (CE-MRA) with standard extracellular contrast material is well established for vascular imaging. Recently, the first blood pool contrast agent (BPA) has become clinically available. This paper reviews characteristics and classification of BPA as well as first clinical experience in various vascular territories. BPAs comprise gadolinium-based compounds, synthetic compounds, and ultrasmall superparamagnetic iron-oxide (USPIO) particles. Such BPAs are retained in blood with a prolonged time-window of enhancement as compared to extracellular gadolinium chelates. Promising results from USPIO at first-pass and steady-state angiography have been published, but no USPIO is approved yet. Gadofosveset is the first clinically approved BPA. After bolus injection, gadofosveset binds noncovalently to serum-albumine, thus enhancing relaxivity. First published results from carotid, coronary, renal, and peripheral angiography are encouraging; particularly helpful is prolonged enhancement during steady state. More BPAs have been clinically evaluated, but no approval has been granted. Bolus-injectable BPAs allow for first-pass CE-MRA similar to standard extracellular contrast media, but with higher relaxivity, allowing lower doses and reduced injection rates. An additional feature of BPA is the steady-state phase with a broad time window enabling high-resolution angiography or double-gated angiography of coronary arteries to compensate for the complex motion pattern.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Rohrer, M., Bauer, H., Mintorovitch, J., Requardt, M., & Weinmann, H. (2005) · Investigative Radiology · doi:10.1097/01.rli.0000184756.66360.d3 · Cited by 1,681
Weissleder, R., & Mahmood, U. (2001) · Radiology · doi:10.1148/radiology.219.2.r01ma19316 · Cited by 1,315
Nephrogenic Systemic Fibrosis: Risk Factors and Incidence Estimation
Sadowski, E. A., Bennett, L. K., Chan, M. R., Wentland, A. L., Garrett, A. L., Garrett, R. W., & Djamali, A. (2007) · Radiology · doi:10.1148/radiol.2431062144 · Cited by 1,011
A Preliminary Report Comparing Magnetic Resonance Coronary Angiography with Conventional Angiography
Manning, W. J., Li, W., & Edelman, R. R. (1993) · New England Journal of Medicine · doi:10.1056/nejm199303253281202 · Cited by 547
MS-325: albumin-targeted contrast agent for MR angiography.
Lauffer, R. B., Parmelee, D. J., Dunham, S. U., Ouellet, H. S., Dolan, R. P., Witte, S., McMurry, T. J., & Walovitch, R. C. (1998) · Radiology · doi:10.1148/radiology.207.2.9577506 · Cited by 457
Functional tumor imaging with dynamic contrast‐enhanced magnetic resonance imaging
Choyke, P. L., Dwyer, A. J., & Knopp, M. V. (2003) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.10304 · Cited by 440
Diagnostic Tests for Renal Artery Stenosis in Patients Suspected of Having Renovascular Hypertension
Vasbinder, G. B. C., Nelemans, P. J., Kessels, A. G. H., Kroon, A. A., de Leeuw, P. W., & van Engelshoven, J. M. A. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-6-200109180-00009 · Cited by 380
Vasbinder, G. B. C., Nelemans, P. J., Kessels, A. G. H., Kroon, A. A., Maki, J. H., Leiner, T., Beek, F. J. A., Korst, M. B. J. M., Flobbe, K., de Haan, M. W., et al. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-9-200411020-00007 · Cited by 365
Nephrogenic systemic fibrosis: a serious late adverse reaction to gadodiamide
Thomsen, H. S. (2006) · European Radiology · doi:10.1007/s00330-006-0495-8 · Cited by 352
Ogan, M. D., Schmiedl, U. P., Moseley, M. E., Grodd, W., Paajanen, H., & Brasch, R. C. (1987) · Investigative Radiology · doi:10.1097/00004424-198708000-00008 · Cited by 275
Research works printed but not linked: 1
- Cavagna FM, Zheng J, Lorusso V, Maggioni F, Li D, Finn PJ (1999) New proton binding Gd chelate with high vascular containment for MR coronary angiography. J Cardio Magn Reson 1:387–388
Cited by
Sorted by citations
Iron oxide nanoparticles: Diagnostic, therapeutic and theranostic applications
Dadfar, S. M., Roemhild, K., Drude, N. I., von Stillfried, S., Knüchel, R., Kiessling, F., & Lammers, T. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.01.005 · Cited by 1,181
Kim, B. H., Lee, N., Kim, H., An, K., Park, Y. I., Choi, Y., Shin, K., Lee, Y., Kwon, S. G., Na, H. B., et al. (2011) · Journal of the American Chemical Society · doi:10.1021/ja203340u · Cited by 957
Interactions of nanomaterials and biological systems: Implications to personalized nanomedicine
Zhang, X., Xu, X., Bertrand, N., Pridgen, E. M., Swami, A., & Farokhzad, O. C. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.08.005 · Cited by 494
25 Years of Contrast-Enhanced MRI: Developments, Current Challenges and Future Perspectives
Lohrke, J., Frenzel, T., Endrikat, J., Caseiro‐Alves, F., Grist, T. M., Law, M., Lee, J. M., Leiner, T., Li, K.-C., Nikolaou, K., et al. (2016) · Advances in Therapy · doi:10.1007/s12325-015-0275-4 · Cited by 420
Emerging applications for ferumoxytol as a contrast agent in MRI
Bashir, M. R., Bhatti, L., Marin, D., & Nelson, R. C. (2014) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.24691 · Cited by 373
Metadata
- Authors
- Bremerich, J., Bilecen, D., & Reimer, P.
- Affiliations
- University Hospital of Basel (CH)
- Städtisches Klinikum Karlsruhe (DE)
- Corresponding author
- Bremerich, Jens
- Venue
- European Radiology
- Published
- 2007-07-17
- Volume
- 17
- Issue
- 12
- Pages
- 3017-3024
- ISSN
- 0938-7994 (ISSN-L)
- 1432-1084
- OpenAlex
- W2032850755
- Cited by
- 139
- References
- 43
- Citations by year
- 2024: 5 · 2022: 5 · 2021: 6 · 2020: 7 · 2019: 4 · 2018: 2 · 2017: 11 · 2016: 14 · 2015: 5 · 2014: 16 · 2013: 7 · 2012: 7
- FWCI
- 1.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- European Radiology (publishedVersion)
- PubMed (publishedVersion)
- reroDoc Digital Library (submittedVersion)
- Topics
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advanced MRI Techniques and Applications
- Physical Sciences › Materials Science › Materials Chemistry › Lanthanide and Transition Metal Complexes
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Cardiac Imaging and Diagnostics
- Keywords
- blood pool contrast agent, contrast-enhanced MR angiography, gadofosveset, ultrasmall superparamagnetic iron oxide, gadolinium-based contrast agents, serum albumin binding, relaxivity, carotid angiography, renal angiography, peripheral angiography
- MeSH terms
- Contrast Media, Dextrans, Gadolinium, Humans, Iron, Organometallic Compounds, Oxides, Vascular Diseases, Magnetic Resonance Angiography, Ferrosoferric Oxide, Magnetite Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
